Clinical Trials
3 trialsNCT02812524 2026-04-24
Ipilimumab for Head and Neck Cancer Patients
Providence Health & Services
Phase 1 Active not recruiting
NCT03752398 2024-07-05
DUET-3
Xencor, Inc.
Phase 1 Completed
NCT01986426 2018-10-03
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
Lytix Biopharma AS
Phase 1 Completed